After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, DTIL falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Precision Biosciences Inc is $67.74M. A total of 0.11 million shares were traded on the day, compared to an average of 163.66K shares.
In the most recent transaction, Kelly John Alexander sold 1,303 shares of DTIL for 6.49 per share on Nov 03 ’25. After the transaction, the Chief Financial Officer now owns 77,298 company shares. In a previous transaction on Nov 03 ’25, Scimeca Dario sold 665 shares at 6.49 per share. DTIL shares that General Counsel and Secretary owns now total 28,258.
Among the insiders who sold shares, Amoroso Michael disposed of 3,409 shares on Nov 03 ’25 at a per-share price of $6.49. This resulted in the President and CEO holding 115,575 shares of DTIL after the transaction. In another insider transaction, Kelly John Alexander bought 1,303 shares at $6.49 per share on Nov 03 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DTIL has a high of $8.82 and a low of $3.61.
As of this writing, DTIL has an earnings estimate of -$0.72 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$1.1. The company reported an EPS of -$2.14 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DTIL’s latest balance sheet shows that the firm has $143.66M in Cash & Short Term Investments as of fiscal 2021. There were $9.11M in debt and $35.98M in liabilities at the time. Its Book Value Per Share was $1.38, while its Total Shareholder’s Equity was $91.17M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DTIL is Buy with a score of 4.60.
